Deutsche Bank’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-39
| Closed | -$82K | – | 3954 |
|
|
2022
Q1 | $82K | Buy |
39
+25
| +179% | +$52.6K | ﹤0.01% | 3599 |
|
|
2021
Q4 | $66K | Buy |
14
+3
| +27% | +$14.1K | ﹤0.01% | 3771 |
|
|
2021
Q3 | $69K | Hold |
11
| – | – | ﹤0.01% | 3923 |
|
|
2021
Q2 | $107K | Buy |
11
+2
| +22% | +$19.5K | ﹤0.01% | 4026 |
|
|
2021
Q1 | $74K | Hold |
9
| – | – | ﹤0.01% | 4032 |
|
|
2020
Q4 | $71K | Buy |
9
+2
| +29% | +$15.8K | ﹤0.01% | 3926 |
|
|
2020
Q3 | $44K | Buy |
7
+2
| +40% | +$12.6K | ﹤0.01% | 3872 |
|
|
2020
Q2 | $38K | Sell |
5
-2
| -29% | -$15.2K | ﹤0.01% | 3859 |
|
|
2020
Q1 | $50K | Hold |
7
| – | – | ﹤0.01% | 3473 |
|
|
2019
Q4 | $110K | Buy |
7
+5
| +250% | +$78.6K | ﹤0.01% | 3472 |
|
|
2019
Q3 | $21K | Sell |
2
-2
| -50% | -$21K | ﹤0.01% | 4121 |
|
|
2019
Q2 | $58K | Buy |
+4
| New | +$58K | ﹤0.01% | 4260 |
|
|
2018
Q4 | – | Sell |
-1
| Closed | -$14K | – | 4652 |
|
|
2018
Q3 | $14K | Buy |
+1
| New | +$14K | ﹤0.01% | 4624 |
|
|
2018
Q2 | – | Hold |
0
| – | -$1K | – | 4887 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4808 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4419 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4431 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4730 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4723 |
|